<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Ewon Comfortech Co., Ltd. -->
          <cik>0001973072</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock , par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/24/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001971387</issuerCik>
        <issuerName>Liminatus Pharma, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>53271X108</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>2251 Stern Goodman Street</com:street1>
          <com:street2>Suite E</com:street2>
          <com:city>Fullerton</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92833</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Ewon Comfortech Co., Ltd.</reportingPersonName>
      <citizenshipOrOrganization>M5</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1126397.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>5500000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5500000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>10.9</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>* Percentage is calculated based on 55,971,633 shares of Common Stock outstanding on July 1, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Liminatus Pharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2251 Stern Goodman Street, Suite E, Fullerton, CA 92833</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Ewon Comfortech Co., Ltd.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>8 Cheomdan 1-ro Jeongeup, Jeonbuk, 56212 Republic of South Korea</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Republic of South Korea</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>5,500,000</amountBeneficiallyOwned>
        <classPercent>10.9</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>1,126,397</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>5,500,000</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Ewon Comfortech Co., Ltd.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Joo Sung Park</signature>
        <title>Joo Sung Park, Chief Executive Officer</title>
        <date>07/06/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
